Number of incontinent men within 6 to 12 months ‐ PFMT + anal EStim + biofeedback versus no treatment · All men after radical prostatectomy
1 finding from 1 review
Incontinence‐specific quality of life · All men after radical prostatectomy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ not reported · All men after radical prostatectomy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Economic analysis using QALY ‐ not reported · All men after radical prostatectomy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of children who received DTP3 or Penta 3 by 1 year of age · children under 5 years of age
Phone call/SMS with/without combination with monetary incentives showed no clear difference in proportion of children who received DTP3 or Penta 3 by 1 year of age… compared with routine care (low certainty).
2 findings from 1 review
Proportion of children who received all recommended vaccines by 2 years of age (phone call/SMS only) · children under 5 years of age
Phone call/SMS with/without combination with monetary incentives showed no clear difference in proportion of children who received all recommended vaccines by 2… compared with routine care (low certainty).
1 finding from 1 review
Proportion of children who received all recommended vaccines by 2 years of age · children under 5 years of age
Phone call/SMS with/without combination with monetary incentives may leads to higher proportion of children who received all recommended vaccines by 2… compared with routine care (low certainty).
1 finding from 1 review
Proportion of children who received the vaccine under study ‐ BCG (phone call/SMS only) · children under 5 years of age
Phone call/SMS with/without combination with monetary incentives showed no clear difference in proportion of children who received the vaccine under study ‐ BCG… compared with routine care (low certainty).
1 finding from 1 review
Proportion of children who received the vaccine under study ‐ BCG (SMS + monetary incentive) · children under 5 years of age
Phone call/SMS with/without combination with monetary incentives showed no clear difference in proportion of children who received the vaccine under study ‐ BCG… compared with routine care (low certainty).
1 finding from 1 review
Proportion of children who received the vaccine under study ‐ OPV3 (phone call/SMS only) · children under 5 years of age
Phone call/SMS with/without combination with monetary incentives showed no clear difference in proportion of children who received the vaccine under study ‐ OPV3… compared with routine care (moderate certainty).
1 finding from 1 review
Proportion of children who received the vaccine under study ‐ OPV3 (phone call/SMS + monetary incentive) · children under 5 years of age
Phone call/SMS with/without combination with monetary incentives showed no clear difference in proportion of children who received the vaccine under study ‐ OPV3… compared with routine care (low certainty).
1 finding from 1 review
Proportion of children who received the vaccine under study ‐ measles/MMR (phone call/SMS + monetary incentive) · children under 5 years of age
Phone call/SMS with/without combination with monetary incentives may leads to higher proportion of children who received the vaccine under study ‐… compared with routine care (low certainty).
1 finding from 1 review
Occurrence of vaccine‐preventable diseases · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cost of the intervention · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Symptom scores over 2 to 4 menstrual cycles1 · women with PMS
1 finding from 1 review
Withdrawals due to adverse events · women with PMS
It is very uncertain whether oestrogen in combination with progestogen (sequential or continuous) changes withdrawal due to adverse events over 2 to 4 menstrual cycles1 compared with placebo (very low certainty).
1 finding from 1 review
Specific adverse events · women with PMS
It is very uncertain whether oestrogen in combination with progestogen (sequential or continuous) changes specific adverse events over 2 to 4 menstrual cycles1 compared with placebo (very low certainty).
1 finding from 1 review
no estimate extracted
206 participants
Very low
Participant‐reported pain relief of 30% or greater · patients with adhesive capsulitis (frozen shoulder)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall pain (change from baseline) · patients with adhesive capsulitis (frozen shoulder)
1 finding from 1 review